ACTIVE

TETRAPHARMAKOS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result58,1 k €-44,1 %over 1 year
Gross margin171,6 k €-13,8 %over 1 year
Equity125 k €-16,7 %over 1 year

Identity

Source · BCE/KBO

TETRAPHARMAKOS is a Private limited company incorporated in 2020. Its registered office is in Ixelles.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0745.344.733
Incorporation
12/03/2020
Legal form
Private limited company
Registered office
Rue Franz Merjay 88 box 1
1050 Ixelles · BruxellesSee on map
Contributed capital
5 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202220212020
Income statement
Gross margin171,6 k €199,1 k €111,7 k €28,2 k €54,6 k €
EBITDA171,5 k €198,5 k €111 k €27,6 k €54,2 k €
Operating result170,5 k €197,8 k €110,1 k €26,8 k €53,1 k €
Net result58,1 k €104 k €48,1 k €19 k €39,9 k €
Balance sheet
Equity125 k €150,1 k €112 k €63,9 k €44,9 k €
Total assets357,7 k €348,8 k €146,3 k €89,4 k €60 k €
Cash296,5 k €297,1 k €111,7 k €75,2 k €46,6 k €
Debts232,2 k €198,7 k €34,3 k €25,5 k €15,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

PANAGIOTIS XAPLANTERIS

Director

Active

Other companies at this address

Rue Franz Merjay 88 1050 Ixelles
CompanyCBE no.
Association des copropriétaires de l'immeuble sis à Ixelles, rue Franz Merjay 88● Active
0835.275.413
LAYERS TECH● Active
0741.959.037

Full financial information

Source · NBB
20252024202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202201/01/202112/03/2020
Closing of the financial year31/12/202531/12/202431/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months10 months
Filing date09/07/202618/07/202529/08/202328/09/202231/08/2021
General meeting08/06/202616/06/202526/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202508/06/202609/07/2026FrenchPDF
Micro model31/12/202416/06/202518/07/2025FrenchPDF
Micro model31/12/202226/05/202329/08/2023FrenchPDF
Micro model31/12/202127/05/202228/09/2022FrenchPDF
Micro model31/12/202028/05/202131/08/2021FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

PANAGIOTIS XAPLANTERIS

Director

Active

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other16/03/2020
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202558,1 k €↓
  2. 2024
    Annual accounts 2024104 k €↑
  3. 2022
    Annual accounts 202248,1 k €↑
  4. 2021
    Annual accounts 202119 k €↓
  5. 2020
    Annual accounts 202039,9 k €
  6. 12/03/2020
    IncorporationPrivate limited company